Fourth-quarter net income rose 62% and the drugmaker has proposed a 25% increase to its annual dividend payment.
twocents@thestreet.com (Joseph Woelfel), The Street
Tue, 01/27/2009 - 11:42pm
Fourth-quarter net income rose 62% and the drugmaker has proposed a 25% increase to its annual dividend payment.